Cardioprotective effects of short-term empagliflozin treatment in db/db mice

Sodium glucose transporter (SGLT)-2 inhibitors have consistently shown cardioprotective effects independent of the glycemic status of treated patients. In this study we aimed to investigate underlying mechanisms of short-term empagliflozin treatment in a mouse model of type II diabetes. Male db/db m...

Descripción completa

Detalles Bibliográficos
Autores principales: Radlinger, Bernhard, Hornsteiner, Florian, Folie, Sabrina, Salvenmoser, Willi, Haubner, Bernhard J., Schuetz, Thomas, Haas, Simone, Ress, Claudia, Adolph, Timon E., Salzmann, Karin, Weiss, Bernhard, Tilg, Herbert, Kaser, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665199/
https://www.ncbi.nlm.nih.gov/pubmed/33184414
http://dx.doi.org/10.1038/s41598-020-76698-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665199/
https://www.ncbi.nlm.nih.gov/pubmed/33184414
http://dx.doi.org/10.1038/s41598-020-76698-8

Ejemplares similares